Latest News and Press Releases

PORTLAND, Ore., July 09, 2026 (GLOBE NEWSWIRE) -- VisCardia, Inc. today announced the first U.S. patient has been implanted in its RECOVER-HF pivotal trial of VisONE™ Synchronized Diaphragmatic...

Both parties intend to approach the collaboration in a spirit of openness, scientific rigor, and shared problem-solving, with the goal of advancing PRP

Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle tissue and reduce fat infiltration in patients with Duchenne muscular dystrophy1Updated open-label extension data...

SkinTE® would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 years, if approved. SkinTE® is a first-in-class...

MedTech BellaSeno is accelerating human trials of its proprietary breast scaffolds as it moves regenerative breast surgery toward clinical adoption.

AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance...

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité ...

TEMPE, Ariz., June 25, 2026 (GLOBE NEWSWIRE) -- Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms...

Kither Biotech announces the successful completion of its Phase 1 clinical study of KIT2014 in healthy participants.